Primary Central Nervous System Vasculitis Following Alemtuzumab Treatment for Multiple Sclerosis A Case Report and Literature Review

被引：1

作者：

Varela, Lucia ^{[1
]}

Pappolla, Agustin ^{[3
]}

Heriz, Alejandra ^{[1
]}

Marquez, Rocio ^{[1
]}

Vega, Otto ^{[1
]}

Christiansen, Silvia ^{[2
]}

Rugiero, Marcelo ^{[1
]}

Midaglia, Luciana ^{[3
]}

Salerno, Annalaura ^{[4
,5
]}

Tintore, Mar ^{[3
]}

Rovira, Alex ^{[4
,5
]}

机构：

[1] Italian Hosp Buenos Aires, Dept Neurol, Buenos Aires, DF, Argentina

[2] Italian Hosp Buenos Aires, Dept Pathol, Buenos Aires, DF, Argentina

[3] Vall dHebron Barcelona Hosp Campus, Multiple Sclerosis Ctr Catalonia Cemcat, Barcelona 08035, Spain

[4] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Sect Neuroradiol, Dept Radiol IDI,Vall dHebron Inst Recerca, Barcelona, Spain

[5] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Magnet Resonance Unit, Dept Radiol IDI,Vall dHebron Inst Recerca, Barcelona, Spain

来源：

NEUROLOGIST | 2023年 / 28卷 / 04期

关键词：

alemtuzumab; multiple sclerosis; seizure; central nervous system vasculitis; encephalitis;

D O I：

10.1097/NRL.0000000000000480

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Introduction:Cerebral vasculitides are often devastating conditions that require immediate diagnosis and treatment. Case report:We report a pathologically proven clinical case of primary central nervous system vasculitis in a 50-year-old man with a diagnosis of relapsing-remitting multiple sclerosis after alemtuzumab therapy, which required additional immunosuppression to control this life-threatening condition. Conclusion:In patients presenting subacute neurological deterioration after alemtuzumab therapy, primary central nervous system vasculitis should be considered as a differential diagnosis among other autoimmune conditions.

引用

页码：270 / 272

页数：3

共 50 条

[11] Autoimmune encephalitis following alemtuzumab treatment of multiple sclerosis [J].

Giarola, Blake ;

Massey, Jennifer ;

Barnett, Yael ;

Rodrigues, Michael ;

Sutton, Ian .

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 28 :31-33

[12] Primary central nervous system tumors in patients with multiple sclerosis [J].

Sabouri, Masih ;

Etemadifar, Masoud ;

Firoozabadi, Fatemeh Dehghani ;

Sindarreh, Setayesh ;

Akhavan-Sigari, Amirhossein .

BMC NEUROLOGY, 2025, 25 (01)

[13] Autoimmune thyroid disease following treatment with alemtuzumab for multiple sclerosis [J].

Alamo, Angela ;

Condorelli, Rosita A. ;

La Vignera, Sandro ;

Calogero, Aldo E. .

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2019, 33

[14] The coincidence of multiple sclerosis and primary vasculitis; from the bench of pathology to the bedside of treatment: a systematic review of case reports [J].

Bafrani, Melika Arab ;

Asadigandomani, Hassan ;

Kasbi, Naghmeh Abbasi ;

Heidari, Hora ;

Eskandarieh, Sharareh .

NEUROLOGICAL SCIENCES, 2025, 46 (01) :351-364

[15] Product review on MAbs (alemtuzumab and ocrelizumab) for the treatment of multiple sclerosis [J].

Gabelic, Tereza ;

Barun, Barbara ;

Adamec, Ivan ;

Krbot Skoric, Magdalena ;

Habek, Mario .

HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (11) :4345-4362

[16] Susceptibility-weighted imaging in the differential diagnosis of autoimmune central nervous system vasculitis and multiple sclerosis [J].

Huang Xuehong ;

Lu Tingting ;

Guo Zhuoxin ;

Wei Lei ;

Chen Shaoqiong ;

Qiu Wei ;

Lu Zhengqi .

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 33 :70-74

[17] Case report of anti-glomerular basement membrane disease following alemtuzumab treatment of relapsing-remitting multiple sclerosis [J].

Meyer, David ;

Coles, Alasdair ;

Oyuela, Pedro ;

Purvis, Annie ;

Margolin, David H. .

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2013, 2 (01) :60-63

[18] An unforeseen reality: Hemophagocytic lymphohistiocytosis following alemtuzumab treatment for a multiple sclerosis [J].

Osep, Anka Blagotinsek ;

Brecl, Eva ;

Skerget, Matevz ;

Savsek, Lina .

CLINICAL NEUROLOGY AND NEUROSURGERY, 2023, 228

[19] Acquired haemophilia A as a secondary autoimmune disease after alemtuzumab treatment in multiple sclerosis: A case report [J].

Pisa, M. ;

Della Valle, P. ;

Coluccia, A. ;

Martinelli, V. ;

Comi, G. ;

D'Angelo, A. ;

Moiola, L. .

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 27 :403-405

[20] Cerebral haemorrhage in the presence of primary childhood central nervous system vasculitis—a review [J].

Karin Pistracher ;

Verena Gellner ;

Stefan Riegler ;

Bernadette Schökler ;

Michael Scarpatetti ;

Senta Kurschel .

Child's Nervous System, 2012, 28 :1141-1148

← 1 2 3 4 5 →